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Objectives. To explore the illicit use of specific prescription stimulants
among college students and add to our understanding of reasons (motives)
and routes of administration associated with illicit use of these drugs.
Methods. A random sample of 4580 college students self-administered a
Web-based survey.  The survey contained a variety of items pertaining to
the illicit use of prescription stimulants.  An extensive list of prescription
stimulants was provided, and students were asked to select all the specific
prescription stimulants that they had used illicitly.  Items were also
included to assess the motives and routes of administration associated with
illicit use of prescription stimulants.
Results. Lifetime and past-year prevalence rates for illicit use of prescription
stimulants were 8.3% (382 students) and 5.9% (269 students), respectively.
Approximately three fourths (75.8%) of the 269 past-year illicit users of
prescription stimulants reported using an amphetamine-dextroamphet-
amine combination agent (e.g., Adderall) in the past year, and approxi-
mately one fourth (24.5%) reported using methylphenidate (e.g., Ritalin,
Concerta, Metadate, Methylin).  Past-year illicit use of prescription
stimulants was more than 3 times more likely among Caucasians (odds
ratio [OR] 3.1, 95% confidence interval [CI] 1.5–6.6) and Hispanics (OR
3.8, 95% CI 1.6–9.3) compared with African-Americans, and more than
twice as likely among Caucasians (OR 2.1, 95% CI 1.3–3.4) and Hispanics
(OR 2.6, 95% CI 1.4–5.1) compared with Asians.  The most commonly
reported motives for illicit use were to help with concentration (65.2%),
help study (59.8%), and increase alertness (47.5%).  Other motives
included getting high (31.0%) and experimentation (29.9%).  Nearly every
illicit user (95.3%) reported oral administration, and 38.1% reported
snorting prescription stimulants.
Conclusion. Illicit use of amphetamine-dextroamphetamine is more
prevalent than illicit use of methylphenidate formulations among college
students.
Key Words: prescription stimulants, illicit use, college students, motives,
amphetamines, methylphenidate, route of administration.
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The illicit use of prescription stimulants by
college students has been well documented over
the past 5 years.1–5 However, with the exception
of methylphenidate formulations, of which
Ritalin (Novartis Pharmaceuticals Corp., East
Hanover, NJ) has received the most attention in
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medical literature, little information is available
regarding which specific stimulants are used
illicitly by college students.  We know of only
two college-based studies2, 6 that have examined
the illicit use of selected prescription stimulants
other than methylphenidate.  The first study,
which used a convenience sample of 150
undergraduate college students, found slightly
higher rates of illicit use for methylphenidate
only (7.3%) compared with amphetamine-
dextroamphetamine only (Adderall; Shire US
Inc., Newport, KY) (4.0%).2 Most notably, it was
found that using both methylphenidate and
Adderall was the most prevalent form of illicit
use of prescription stimulants (24.0%).  The
second study used 26 “purposefully selected”
students who were familiar with drug use.6
According to these students’ perceptions,
Adderall was used more than other prescription
stimulants on their campus due to its availability
and lower occurrence of “ups and downs.”
Students in this sample were not representative of
the entire student body, and self-reported
prevalence rates were not provided.  To our
knowledge, these studies, although limited in
their design, are the only published college-based
investigations that have specifically examined
illicit use of amphetamine-dextroamphetamine
combination products.
Limited data exist regarding which specific
prescription stimulants are used illicitly among
students in other age groups.  For example, a
2004 study reported the following past-year
prevalence rates of illicit amphetamine use
among high school seniors:  2.3% Ritalin, 1.9%
methamphetamine, 0.7% Dexedrine, 0.2%
Benzedrine, 0.2% Methedrine, 0.1% Preludin,
and 0.1% Dexamyl.7 As with studies of the
general population,8 that study did not assess
illicit use of amphetamine-dextroamphetamine
formulations.  Because these formulations are
among the most commonly prescribed stimulants
for treatment of attention-deficit–hyperactivity
disorder (ADHD), it is crucial to determine the
extent of their illicit use.
Data are also scarce with regard to the
prevalence of illicit use of specific prescription
stimulants in both high school and college
students.  In addition, comprehensive surveys of
motives for illicit stimulant drug use are needed,
particularly in light of a growing body of
evidence indicating several possible motives for
illicit use of prescription stimulants.  In one
study, the primary reasons students provided for
illicitly using prescription stimulants were to
help concentrate, increase alertness, and get
high.9 Of note, many students also wrote in “to
study” as a motive that was not provided as a
fixed item in the survey; this motive needs to be
empirically tested.  Finally, at least one other
study that we are aware of has assessed routes
other than oral administration for stimulant
drugs among college students.1 According to that
study, almost 13% of 283 students sampled had
used methylphenidate intranasally.
Development of clinical, prevention, policy,
and educational strategies for reducing prescription
stimulant abuse requires knowledge of which
agents are being abused and insight into motives
for drug use and the routes by which these agents
are being administered.  We sought to address
these gaps in knowledge by assessing the
prevalence of illicit use of specific prescription
stimulants within a large, randomly selected
sample of undergraduate college students.  We
also examined students’ reasons for illicit use of
prescription stimulants, using a comprehensive
list of motives that evolved from earlier research,9
and explored the routes of illicit drug
administration.
Methods
Design
This study was approved by the institutional
ethical review board at a large midwestern
university and was conducted at that university
during a 2-month period in January and
February of 2005.  A random sample of 5389
full-time undergraduate students was drawn from
the total undergraduate population of 20,138
full-time students (10,339 women, 9799 men).
In addition, we oversampled 652 Hispanic, 634
African-American, and 244 Asian undergraduate
students in order to produce reliable prevalence
estimates for these racial and ethnic groups.  The
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entire sample was mailed a prenotification letter
with $2 enclosed.  This letter described the study
and invited students to self-administer a
confidential Web survey by using a URL address
and a unique password.  Nonrespondents were
sent up to three reminder e-mails.  The survey
was maintained on an Internet site with the
secure socket layer protocol to ensure privacy
and security.  By participating in the survey,
students became eligible for a sweepstakes that
included cash prizes, travel vouchers, field passes
to athletic events, and iPods.  The final response
rate was 66%, which exceeded the average
response rate for national college-based studies of
alcohol and other drugs.10 Similar Web-based
study designs and procedures are described in
more detail elsewhere.11
Sample
The final sample consisted of 4580 undergraduate
students and closely resembled the demographic
characteristics of the overall student population.
Fifty percent were women.  The sample consisted
of 65% Caucasians, 13% Asians, 7% African-
Americans, 4% Hispanics, and 11% Native-
Americans and other racial categories.  The mean
± SD age of students in the sample was 20 ± 2.0
years.
Measures
As shown in Figure 1, computerized skip logic
was used to guide students through survey
questions pertaining to illicit use of prescription
stimulants.  Students received follow-up questions
only if they acknowledged having illicitly used
prescription stimulants during their lifetime.
Survey questions about motives for illicit use of
prescription stimulants were based on our earlier
work9 and were not mutually exclusive (i.e.,
students could report more than one reason).  It
should be noted that our survey items included
both generic and brand names in order to
increase clarity for respondents.  However, we
use generic names exclusively in our description
of our findings.
Statistical Analysis
In the initial analysis, the overall prevalence
rates for lifetime and past-year illicit use of
prescription stimulant drugs were examined.  We
also calculated prevalence rates for illicit use of
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Figure 1. Flow diagram representation of measures and skip logic used during self-administration of the Web-based survey.
Sometimes people use prescription drugs that were meant for other people, even when their own doctor has not prescribed it for them.
On how many occasions in your lifetime have you used the following types of drugs, not prescribed to you?
 
Stimulant medication (e.g., Ritalin, Dexedrine, Adderall, Concerta, methylphenidate).
Response scale: ranged from (1) No occasions to (7) 40 or more occasions [also included (8) Rather not say]
COMPUTERIZED SKIP LOGIC (those endorsing the
LIFETIME illicit use of prescription stimulants)
Stimulant medication (e.g., Ritalin,
 Dexedrine, Adderall, Concerta,
 methylphenidate).
Response scale: ranged from
 (1) No occasions to (7) 40 or
 more occasions [also included
 (8) Rather not say]
Stimulant medication (e.g., Ritalin,
 Dexedrine, Adderall, Concerta,
 methylphenidate).  
Responses included: “Grade K-4,”
 “Grade 5–6,” “Grade 7–8,”
 “Grade 9–10,” “Grade 11–12,”
 “College,” and “Rather not say.”
For purposes of analysis, these
 categories were collapsed into
 “precollege initiators” and
 “college initiators.” 
(1) Because it helps me concentrate
(2) Because it helps increase my alertness
(3) Because it gives me a high
(4) Because it counteracts the effects of
 other drugs
(5) Because it helps me study
(6) Because it helps me lose weight
(7) Because of experimentation
(8) Because it’s safer than street drugs
(9) Because I’m addicted
(10) Other (specify)
(11) Rather not say 
Which of the following routes
 of administration have you
 used for taking stimulant
 medications not prescribed
 to you:
Response categories were:
 (1) Orally
 (2) Snorting
 (3) Smoking
 (4) Injecting
 (5) Inhaling
 (6) Other (specify)
COMPUTERIZED SKIP LOGIC
(those endorsing the PAST-YEAR
illicit use of prescription stimulants)
Please indicate if you have used any of the following stimulants not prescribed to you in the past 12 months (select all that apply):
(1) Amphetamine (e.g., Benzedrine), (2) Amphetamine/dextroamphetamine (e.g., Adderall), (3) Methamphetamine (e.g., Desoxyn),
(4) Methylphenidate (e.g., Ritalin, Concerta, Metadate, Methylin), (5) Modafinil (e.g., Provigil), (6) Pemoline (e.g., Cylert),
(7) Other (please specify), (8) Don’t know the names of some I have used, (9) None, (10) Rather not say. 
Please provide the reason(s) why you
 used stimulant medication not
 prescribed to you (select all that apply):
When did you first start using
 each drug, not prescribed to
 you by a doctor?
On how many occasions in the
 past 12 months have you used
 the following types of drugs,
 not prescribed to you?
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prescription stimulants for subgroups defined by
sex, race-ethnicity, and age of onset.  Data were
weighted to account for the overall student
population sampling fractions.  We used multiple
logistic regression analyses to examine associa-
tions between these subgroups and illicit use of
prescription stimulants.  Prevalence rates of
motives for illicit use of prescription stimulants
among lifetime users were also calculated, and x2
analyses were used to test for differences in
motives by sex, race-ethnicity, and age of onset.
Finally, prevalence rates for routes of adminis-
tration of prescription stimulants by lifetime
users were calculated, and x2 analyses were
performed to test for differences in routes of
administration by sex, race-ethnicity, and age of
onset.  An a level of 0.05 was used for each
statistical test.
Results
Prevalence of Illicit Use of Specific Stimulants
Three-hundred eighty-two (8.3%) of the 4580
respondents had used illicit prescription
stimulants in their lifetime, and 269 (5.9%) had
used illicit prescription stimulants in the past
year. As shown in Table 1, approximately three
of every four (75.8%) illicit prescription
stimulant users reported taking amphetamine-
dextroamphetamine in the past year, and
approximately one in four (24.5%) reported
using methylphenidate products.  Less than 3%
each was reported for modafinil, amphetamine,
methamphetamine, or pemoline.  There were no
differences in the past-year illicit use of prescrip-
tion stimulants between men and women.
However, there were statistically significant
ethnic-racial differences in past-year use:
Hispanics 8.5%, Caucasians 7.0%, Asians 3.4%,
African-Americans 1.9%, and those categorized
as other 3.6% (x2 39.7, df=4, p<0.001; Figure 2).
The effects of race and ethnicity were further
examined in a series of multiple logistic
regression analyses.  Four dummy variables were
constructed to represent the information for the
five-category race-ethnicity variable.  When
African-Americans were used as the reference
group, the odds of past-year illicit use of
prescription stimulants were more than 3 times
higher among Caucasians (odds ratio [OR] 3.1,
95% confidence interval [CI] 1.5–6.6) and
Hispanics (OR 3.8, 95% CI 1.6–9.3).  There were
no statistically significant differences between
Asians and African-Americans in the odds of
past-year illicit use of prescription stimulants.
Analyses using Asians as the reference group
showed that the odds of past-year illicit use of
prescription stimulants were over twice as high
among Caucasians (OR 2.1, 95% CI 1.3–3.4) and
Hispanics (OR 2.6, 95% CI 1.4–5.1).  A final
analysis using Caucasians as the reference group
showed that there was no statistically significant
difference between Caucasians and Hispanics in
the odds of past-year illicit use of prescription
stimulants.
Most lifetime illicit prescription stimulant
users began using in college (65.2%) compared
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Table 1.  Specific Prescription Stimulants Used in the Past
Year by 269 Students (weighted dataa) Reporting Illicit
Use of Any Prescription Stimulant
No. (%)b
Stimulant of Users
Amphetamine-dextroamphetamine
(e.g., Adderall) 204 (75.8)
Methylphenidate (e.g., Ritalin,
Concerta, Metadate, Methylin) 66 (24.5)
Modafinil (e.g., Provigil) 7 (2.6)
Amphetamine (e.g., Benzedrine) 7 (2.4)
Methamphetamine (e.g., Desoxyn) 2 (0.8)
Pemoline (e.g., Cylert) 0 (0.0)
Other 4 (1.6)
Don’t know the names of some
I have used 9 (3.2)
Rather not say or did not specify 29 (11.0)
aData were weighted to account for the overall student populations
sampling fractions.
bTotal exceeds 100% because respondents were instructed to check
all categories that applied.
Figure 2. Past-year prevalence of illicit use of prescription
stimulants as a function of race-ethnicity (4478 students,
weighted data).  The dashed line represents overall
prevalence rate for past-year illicit use of prescription
stimulants.
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with precollege (34.8%).  Logistic regression
analysis showed that students who began illicitly
using prescription stimulants before college were
almost 3 times more likely than students who
began using in college to report illicit use of
prescription stimulants in the past year (OR 2.8,
95% CI 1.8–4.5).
Motives for Illicit Use
As shown in Table 2, the most commonly
reported motives for illicit use of prescription
stimulants were to help with concentration
(65.2%), help study (59.8%), and increase
alertness (47.5%).  Other common motives were
to get high (31.0%) and to experiment (29.9%).
Sex-based differences emerged for several
categories of motives.  To experiment was
reported by 34.6% of men versus 18.2% of
women (p<0.05), and to counteract the effect of
other drugs was cited by 7.4% of men versus
1.8% of women (p<0.05).  In contrast, women
were more likely than men to report using
prescription stimulants to lose weight (18.2% vs
3.2%, p<0.001), to help study (66.7% vs 54.8%,
p<0.05), and to help increase alertness (58.8% vs
38.7%, p<0.001).  Finally, there were no sex
differences in the most frequently reported
motive, which was to help concentrate.  Sex-
based comparisons for the most commonly
reported motives are presented in Figure 3.
Some ethnic-racial differences were also
observed with regard to motivation.  To get high
was not reported by any African-Americans,
whereas it was cited by significant percentages of
prescription stimulant abusers in other
categories:  Caucasians 32.4%, Asians 21.9%,
Hispanics 21.4%, and others 46.2% (x2 9.6, df=4,
p<0.05).  Similar results were found for the
motive to experiment; that is, Caucasians, Asians,
Hispanics, and others were more likely than
African-Americans to report this as a motive (x2
10.8, df=4, p<0.05).  Most African-American
illicit prescription stimulant users reported to
help concentrate (eight students) and to help
study (six students) as their motive for use.
Finally, there were differences in motives based
on when students began illicit use of prescription
stimulants (Figure 3).  Compared with students
who started before college, students who started
during college were more likely to report the
motives of improving concentration (70.7% vs
55%, p<0.01) and helping to study (66.5% vs
48.9%, p=0.001).  Conversely, precollege illicit
users of prescription stimulants were more likely
than their counterparts to report using these
agents to get high (46.6% vs 22.8%, p<0.001), to
lose weight (15.3% vs 6.5%, p<0.01) and to
experiment (42.0% vs 24.0%, p<0.001).
Routes of Administration
As shown in Table 2, nearly every illicit
prescription stimulant user (95.3%) reported oral
administration, and 38.1% reported snorting
these agents.  A much smaller proportion of illicit
users reported smoking stimulants (5.6%), and
less than 1% was reported for other routes of
administration, such as inhalation and injection.
We examined associations between sex, race-
ethnicity, grade of onset, and the three most
frequent routes of administration (oral, intranasal,
and smoking).  Neither sex nor race-ethnicity
was significantly associated with any route of
administration.  There was also no difference in
rates of oral administration between students
who started during college versus before college.
However, students who began illicitly using
prescription stimulants before college were more
likely to report snorting prescription stimulants
(54.2%) than those who started during college
(30.5%) (x2 20.25, df=1, p<0.01).  Further, those
who reported precollege onset of illicit prescrip-
tion stimulant use were more likely to report
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Table 2.  Motives and Routes of Administration for Illicit
Use of Prescription Stimulants Reported by 382 Lifetime
Users (weighted dataa)
Variable No. (%) of Users
Motive
Because it helps me concentrate 249 (65.2)
Because it helps me study 228 (59.8)
Because it helps increase my
alertness 181 (47.5)
Because it gives me a high 118 (31.0)
Because of experimentation 114 (29.9)
Because it helps me lose weight 37 (9.7)
Other (specify) 19 (5.0)
Because it counteracts the effects
of other drugs 18 (4.8)
Because it is safer than street drugs 17 (4.5)
Because I’m addicted 4 (1.0)
Rather not say 2 (0.5)
Route of Administration
Orally 363 (95.3)
Snorting 145 (38.1)
Smoking 22 (5.6)
Inhaling 2 (0.6)
Injecting 0 (0.0)
Other (specify) 2 (0.4)
aData were weighted to account for the overall student populations
sampling fractions.
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smoking these agents (11.5%) than those whose
onset was during college (2.8%) (x2 11.52, df=1,
p<0.01).
Discussion
Prevalence of Illicit Use of Specific Prescription
Stimulants
The lifetime and past-year prevalence rates of
illicit use of prescription stimulants found in our
study resemble findings from single-institution9
and national studies4, 5 of college students that
used similar survey items.  To our knowledge,
this is the first study to provide evidence that
amphetamine-dextroamphetamine is being
illicitly used by college students at higher rates
than methylphenidate.  In fact, amphetamine-
dextroamphetamine was reported more frequently
than any other stimulants assessed in our study.
Two hundred four (75.8%) of the 269 past-year
illicit users reported having taken amphetamine-
dextroamphetamine, whereas only 66 (24.5%)
reported having taken methylphenidate.  Forty-
eight students (18.0%) reported using both
amphetamine-dextroamphetamine and methyl-
phenidate.
In the only other study of college students that
provided prevalence rates for illicit use of
amphetamine-dextroamphetamine, students
reported using methylphenidate at higher rates
than amphetamine-dextroamphetamine (7.3% vs
4.0%), and the use of both was reported by 24%
of respondents, thus exceeding the prevalence of
either drug alone.2 The difference in findings
may be explained by changing trends in illicit use
of specific prescription stimulants or by
differences in survey methodology.
The popular press often identifies Adderall as
being one of the primary prescription stimulants
used illicitly by high school and college
students.12–14 Our study is the first to empirically
document this claim using random sampling of
an undergraduate student population.  Further-
more, our findings suggest that other studies may
benefit by asking specifically about amphet-
amine-dextroamphetamine products, as studies
that overlook these agents may seriously
underestimate the prevalence of prescription
stimulant abuse among adolescents and young
adults.  However, it should be noted that
differences in methodology often make it difficult
to directly compare studies that assess the illicit
use of prescription stimulants.15 Different studies
have included various brand names and
formulations in their surveys, and whereas some
have listed the brand names as individual
choices, other studies have grouped multiple
brand names together as a single item.  For
example, many national studies of prescription
stimulant abuse have included methylphenidate
and/or Ritalin as individual items, but they have
not specifically included amphetamine-
dextroamphetamine products.4, 8
Several hypotheses have been suggested as to
why illicit use of amphetamine-dextroamphetamine
appears to be growing relative to other stimulant
formulations.  These hypotheses generally fall
into three categories:  availability, pharmacokinetic
differences between stimulant drugs, and
pharmacologic differences between stimulant
drugs.  For example, in one of the few other
studies to specifically address illicit use of
amphetamine-dextroamphetamine, college
students reported that they believed Adderall was
popular for illicit use because it was easily
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Figure 3. Relationships between the most commonly
reported motives for illicit use of prescription stimulants
and sex (A) and age of initiation of illicit use of prescription
stimulants (B) among 382 students reporting lifetime illicit
use of prescription stimulants (weighted data).
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accessible, caused fewer emotional ups and
downs (than alternative agents), and was
believed to work better overall.6 Although that
study6 did not use a random, representative
sample of students or assess medical availability
of stimulant drugs, it still provides insight as to
why illicit amphetamine-dextroamphetamine use
is growing on college campuses.
Pharmacokinetic differences among various
formulations support students’ perceptions of
experiencing less ups and downs with certain
agents compared with others.  For example,
Adderall XR is an extended-release formulation
with a duration of action of approximately 10–12
hours.  This is significantly longer than the
duration of action of most methylphenidate
formulations, with the exception of Concerta
(methylphenidate; McNeil Consumer & Specialty
Pharmaceuticals, Fort Washington, PA).
Immediate-release methylphenidate lasts at most
for 6 hours; this short duration of action may
contribute to perceived emotional fluctuations.
In fact, among children with ADHD, this short
duration of action and resultant multiple daily
dosing has led to the so-called roller coaster
response.16
The mechanism of action of amphetamine-
dextroamphetamine may also be a factor in its
increasing popularity among illicit prescription
stimulant users.  Like methylphenidate, amphet-
amines increase dopamine levels in the brain by
blocking the dopamine transporter.  However,
amphetamines also cause presynaptic release of
dopamine.  Thus, amphetamine-dextroamphet-
amine may generate higher dopamine levels in
the brain than occur after taking methylphenidate
products.17 Furthermore, amphetamine-dextro-
amphetamine increases levels of norepinephrine,
which has been associated with improved
cognitive functioning.18 Some researchers have
speculated that these differences in mechanism
(i.e., higher dopamine levels and the addition of
noradrenergic effects) may explain why patients
with ADHD respond differently to different
stimulant drugs.19 College students may also
experience subjectively better responses to
certain stimulants when illicitly using them to
enhance their academic performance.
To our knowledge, no study has specifically
assessed the relationship between availability of
specific prescription stimulants and their illicit
use.  However, as Adderall XR is the most
commonly prescribed brand-name prescription
stimulant in the United States,19 it is possible that
increased availability has resulted in increased
illicit use.  This hypothesis is purely speculative
until it can be adequately tested using valid data
on medical availability.
The findings that African-Americans were less
likely than Hispanics and Caucasians to report
illicit prescription stimulant use accord with
results from a national college-based study5 and a
national study of 8th, 10th, and 12th graders.20
Both studies found that African-American youths
were less likely than other students to report
illicit use of methylphenidate.  It appears that
African-American students of various ages report
less illicit use of prescription stimulants.  In fact,
according to a national survey of high school
seniors, African-American students reported less
substance use overall than most other racial-
ethnic categories.21 It is unclear why African-
American students are reporting less drug use,
including illicit use of prescription stimulants.
African-Americans have more conservative
norms and attitudes toward the use of alcohol.22
Thus, it is possible that these attitudes are also
held by African-American students with regard to
illicit use of prescription stimulants.
Motives for Illicit Use
This study builds on our earlier findings that
college students are illicitly using prescription
stimulants for a variety of reasons.9 In particular,
students report motivation to enhance their
academic performance, with most illicit users of
prescription stimulants reporting improved
concentration and help with studying as their
motives for illicit use.  Attention to motives for
substance abuse is important because users’
motives are often linked to other behaviors
associated with drug use.  For example, research
on motivations for alcohol use has shown that
mood regulation is an important reason for
drinking alcohol.23 Our findings highlight the
importance of the academic environment (e.g.,
level of competitiveness) as a factor that may
increase motivations for illicit stimulant use.
They also illustrate the heterogeneous nature of
motivations for stimulant abuse.5
Our study revealed several sex-based
differences in motives for illicit stimulant use.
These findings conflict with our own previous
findings9 as well as those of other researchers.2, 24
Of particular interest is evidence that academic-
related motivations for illicit prescription
stimulant use (i.e., to help study or help increase
alertness) are more salient for women than for
men.  To our knowledge, this is the first study to
1507
PHARMACOTHERAPY  Volume 26, Number 10, 2006
report sex-based differences in motivations for
illicit stimulant use.  Discrepancies between our
results and findings from earlier studies may be
related to differences in survey methodology.  For
example, three items for which we found sex-
based differences in this study (to help study,
experiment, and lose weight) were not included
in our previous survey as fixed items.9 However,
two other motives for which we found sex-based
differences in this study (increase alertness,
counteracts the effects of other drugs) were
included in our previous survey, which did not
show sex-based differences.  It may be that sex-
based differences in motives for illicit prescrip-
tion stimulant use are increasing over time, but
this hypothesis can be tested only with
longitudinal data.
Our study is also the first we are aware of to
document ethnic-racial differences in students’
motives for illicit prescription stimulant use.  In
particular, African-Americans who reported the
illicit use of prescription stimulants were less
likely to cite getting high or experimentation as
motives than stimulant users in other ethnic
groups.  This finding may be related to the lower
prevalence rates of illicit use of prescription
stimulants among African-Americans as compared
with other student populations.  These findings
need to be validated by other studies before firm
conclusions can be made.
Finally, it is interesting that the motives to help
study and to improve concentration were
reported more frequently by students who began
illicit use of prescription stimulants in college
rather than before college.  This finding suggests
that some students are seeking academic
performance enhancement through the help of
prescription stimulants once they arrive at
college.  It may be that some students are more
vulnerable than others to the pressures of college
life and are more likely to use stimulants and
other substances to cope with this pressure.
Clearly, more work is needed to explore the
implications of age of onset for illicit prescription
stimulant use, especially with regard to the effects
of stimulant use on academic performance.
Routes of Administration
Whereas most illicit prescription stimulant
users reported oral administration, it is notable
that 38% of illicit users reported snorting
prescription stimulants.  One other study
assessed this behavior among college students
and found that almost 13% of the students used
methylphenidate intranasally.1 Clearly, this form
of drug use needs to be addressed through
education and prevention, as the pharmaco-
kinetics of prescription drugs can be dramatically
altered when they are taken by routes other than
the ones for which they are intended.  For
example, the effects and hence the abuse liability
of methylphenidate are increased when it is taken
by routes that cause rapid increases in serum
concentrations (e.g., injection, insufflation).25
Hence, college students who use prescription
stimulants by alternate routes of administration,
such as intranasal, may be increasing their
vulnerability for dependence on these drugs,
even if they started for apparently innocuous
purposes (e.g., to enhance studying).
Information about routes of illicit drug
administration is crucial to the development of
clinical, prevention, policy, and educational
efforts for reducing these behaviors and the
negative consequences that may result.  The
United States Food and Drug Administration
(FDA) has shown recent attention to the
cardiovascular risks associated with prescription
amphetamine-dextroamphetamine products.  In
fact, the FDA has developed a Web site
(http://www.fda.gov/cder/drug/infopage/adderall/
default.htm) that both patients and clinicians can
access to learn more about the health risks
associated with Adderall and Adderall XR.
Whereas most individuals exposed to prescription
stimulants are unlikely to experience serious
adverse events, students who illicitly use
prescription stimulants without appropriate
medical advice may be putting themselves at risk,
particularly if they use an alternative route of
administration.  Given the widespread illicit use
of prescription stimulants reported on U.S.
college campuses, students, clinicians, and others
who interact with students must be educated
about the potential adverse events associated
with these potent psychostimulants.
Limitations
Several limitations should be considered before
assessing the implications of our findings.  Our
sample consisted of students from a single
university, which may limit the generalizability of
our results.  Although the prevalence rates of
illicit use of prescription stimulants in this
single-institution study were comparable to those
found in national surveys of college students,4, 5
similar investigations need to be conducted in
diverse samples, including young adults who are
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not attending college, to assess the generality of
the findings.
Although we achieved an adequate response
rate, nonresponse may have introduced bias in
our study.  However, concerns regarding non-
response were reduced because the demographic
characteristics of the sample closely resembled
those of the overall student population.  In
addition, we assessed the potential impact of
nonresponse by administering a brief telephone
survey to 159 nonrespondents and found no
significant differences in alcohol and other drug
use between respondents and nonrespondents.
This study did not include an individual survey
item for dextroamphetamine (e.g., Dexedrine;
GlaxoSmithKline, Research Triangle Park, NC).
However, in a national survey of high school
seniors that includes a survey item for Dexedrine,
the annual prevalence rate of illicit use of
Dexedrine has not risen above 1% since 1985.7
Furthermore, a recent report using data from IMS
Health’s NPA Plus (1992–2002) demonstrates
that the use of dextroamphetamine represents a
small percentage of the overall number of filled
stimulant prescriptions.26 Therefore, it seems
unlikely that the omission of dextroamphetamine
products in our survey would have had a large
impact on our findings.  Also, our study did not
distinguish between various formulations of each
stimulant (e.g., Adderall vs Adderall XR), which
may have important clinical and/or research
implications.  Finally, this study did not contain
diagnostic information such as ADHD, which
would help us determine which students may be
self-medicating due to untreated ADHD.
Future Directions for Research
Studies to investigate the impact of psycho-
stimulants on academic performance are needed;
in particular, studies to explore any differences in
academic performance based on specific
stimulants with varying mechanisms of action
will contribute to our knowledge regarding the
illicit use of prescription stimulants.  More work
is clearly needed to assess ethnic-racial differ-
ences in the prevalence of illicit use of prescrip-
tion stimulants in diverse populations, including
nonacademic environments, in addition to
validating our findings among other samples of
college students.  Future work should examine
whether intranasal administration increases a
student’s vulnerability for abuse and/or depend-
ence.  This should include an assessment of age
of initiation of illicit prescription stimulant use as
this was shown to have an impact on the route of
administration; precollege illicit users were more
likely to report intranasal administration or
smoking as a route of administration for prescrip-
tion stimulants.  It is unknown why precollege
illicit stimulant users report higher rates of
nonoral administration compared with college
initiators, but it may be associated with differ-
ences in motives for use between the two groups.
This also must be further elucidated through
research efforts.
The impact of pharmaceutical delivery systems
on the abuse potential of prescription psycho-
stimulants would clearly provide valuable
information on this potential approach to
decreasing the illicit use of these drugs.  For
example, one study found that a once-daily
osmotic controlled-release formulation of
methylphenidate had less abuse potential than
immediate-release methylphenidate.27 However,
the impact of such delivery systems on long-term
development of substance abuse and dependence
are unknown.
Conclusion
Amphetamine-dextroamphetamine was clearly
the most prevalent stimulant drug used illicitly
by college students, at rates 3 times higher than
that of methylphenidate formulations (e.g.,
Ritalin, Concerta, Metadate, Methylin).  Thus,
studies that rely solely on methylphenidate as an
indicator for illicit use of prescription stimulants
may underestimate the prevalence of this form of
drug abuse.
Hispanic and Caucasian students had higher
rates of illicit prescription stimulant use than
Asians and African-Americans, but no sex-based
differences in use were apparent.  College students
are illicitly using prescription stimulants for a
variety of reasons, with academic performance
ranking among the top.  In fact, the three most
commonly reported motives for illicit use of
prescription stimulants seemed related to a desire
for enhanced academic performance.  Motives
linked to academic performance were higher in
women than in men and in students who began
illicit use of prescription stimulants in college
versus before college.  Our findings of high rates
of intranasal use of prescription stimulants
highlight the need for education and prevention
efforts aimed at reducing this dangerous behavior.
Clinicians who prescribe stimulant drugs to
their patients carry the responsibility of weighing
the benefits and risks of these agents.  Prescription
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stimulants are highly effective for treating ADHD
and other conditions.  However, if they are used
without appropriate therapeutic monitoring and
management, dangerous health consequences can
occur.
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